Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
1(8%)
Results Posted
63%(5 trials)

Phase Distribution

Ph not_applicable
4
33%
Ph phase_2
3
25%
Ph phase_3
4
33%
Ph phase_4
1
8%

Phase Distribution

0

Early Stage

3

Mid Stage

5

Late Stage

Phase Distribution12 total trials
Phase 2Efficacy & side effects
3(25.0%)
Phase 3Large-scale testing
4(33.3%)
Phase 4Post-market surveillance
1(8.3%)
N/ANon-phased studies
4(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

8 of 8 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

12

all time

Status Distribution
Active(1)
Completed(8)
Other(3)

Detailed Status

Completed8
unknown3
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 23 (25.0%)
Phase 34 (33.3%)
Phase 41 (8.3%)
N/A4 (33.3%)

Trials by Status

unknown325%
completed867%
recruiting18%

Recent Activity

1 active trials
Showing 5 of 12
recruitingnot_applicable

Tract Closure in PCNL

NCT07668817
completedphase_3

The EVARREST® Paediatric Mild/Moderate Liver and Soft Tissue Bleeding Study

NCT02227992
completednot_applicable

Efficacy and Safety of HemoStyp as an Adjunct for Management of Secondary Hemostasis in the Operative Setting

NCT03654560
completedphase_2

Surgicel Reduces Ovarian Endometriomas Recurrence

NCT02947724
completedphase_3

Traumastem® Versus Surgicel® for the Secondary Treatment of Local Bleeding in Patients Undergoing Hepatic Resection

NCT03489070
View all 12 trials

Clinical Trials (12)

Showing 12 of 12 trials
NCT07668817Not Applicable

Tract Closure in PCNL

Recruiting
NCT02227992Phase 3

The EVARREST® Paediatric Mild/Moderate Liver and Soft Tissue Bleeding Study

Completed
NCT03654560Not Applicable

Efficacy and Safety of HemoStyp as an Adjunct for Management of Secondary Hemostasis in the Operative Setting

Completed
NCT02947724Phase 2

Surgicel Reduces Ovarian Endometriomas Recurrence

Completed
NCT03489070Phase 3

Traumastem® Versus Surgicel® for the Secondary Treatment of Local Bleeding in Patients Undergoing Hepatic Resection

Completed
NCT03176992Phase 2

Surgicel® & Endometrial Ablation in the Management of Perimenpausal Heavy Menstrual Bleeding

Unknown
NCT01731938Phase 3

Safety and Efficacy of Fibrin Sealant Grifols (FS Grifols) During Soft Tissue Open Surgeries

Completed
NCT01754480Phase 3

Safety and Efficacy of Fibrin Sealant Grifols (FS Grifols) During Parenchymous Tissue Open Surgeries

Completed
NCT00837954Phase 4

Trial to Evaluate the Hemostatic Effect of Lyostypt® Versus Surgicel® in Arterial Bypass Anastomosis

Completed
NCT02054260Not Applicable

Surgicel® (Fibrillar) in Non-variceal UGI Bleeding

Unknown
NCT00658723Phase 2

The Fibrin Patch Soft Tissue Study

Completed
NCT01756534Not Applicable

Oxidized Cellulose Hemostatic Agent in Thyroid Surgery: a Prospective Randomized Controlled Study

Unknown

All 12 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
12